Kooperativer Bibliotheksverbund

UID:

Umfang: 1 online resource (642 p.)

ISBN: 9780128020098 , 0128020091

Anmerkung: Description based upon print version of record. , Front Cover; Dedication; Systemic Lupus Erythematosus; Copyright; Contents; List of Contributors; Introduction; I - Epidemiology and Diagnosis; 1 - History of Systemic Lupus Erythematosus; REFERENCES; 2 - The Patient; IMPROVE THE INTERACTIONS WITH YOUR PATIENTS; Do Not Make Your Patient Wait; Smile as You Enter the Patient's Room; Exhibit a Visible Show of Hand Washing; Shake Hands; Acknowledge and Greet Others in the Room; Sit Down When You Talk to Your Patients; Body Position; Ask Open-Ended Questions; Provide a Mechanism for Your Patient to Set the Agenda; Speak in Nonmedical Terms , Be Honest and CompassionateAlways Examine Your Patient; End the Visit with, "Do You Have Any Other Concerns or Questions?"; Consulting in the Hospital; IMPROVING COMPLIANCE; COMMON PITFALLS; DISABILITY; PATIENT EDUCATION; THE LUPUS SECRETS; REFERENCES; 3 - Epidemiology; SUMMARY; INTRODUCTION; INCIDENCE AND PREVALENCE; Distribution According to Gender; Distribution According to Age; Distribution According to Ethnic/Racial Group; Distribution Around the World; FACTORS THAT AFFECT THE COURSE OF SLE; Impact of Race/Ethnicity; Impact of Gender; Impact of Age; MORTALITY AND SURVIVAL IN SLE , REFERENCES4 - Measuring Disease Activity; SUMMARY; REFERENCES; 5 - Disease Development and Outcomes; HISTORICAL PERSPECTIVE; CLINICAL MANIFESTATIONS; ASSESSMENT OF DISEASE ACTIVITY; DISEASE DAMAGE; PATIENT-REPORTED OUTCOMES; MORTALITY; CAUSES OF DEATH; TREATMENT GUIDELINES AND QUALITY INDICATORS; CONCLUSIONS; REFERENCES; 6 - Socioeconomic Aspects of Systemic Lupus Erythematosus; SUMMARY; DEFINITION AND MEASURES OF SOCIOECONOMIC STATUS; PROBLEMS WITH MEASURING SES IN HEALTH RESEARCH; IMPACT OF SES ON SYSTEMIC LUPUS ERYTHEMATOSUS OUTCOMES; DISEASE ACTIVITY; DAMAGE ACCRUAL; DISABILITY; MORTALITY , CONCLUSIONSREFERENCES; 7 - Biomarkers in Systemic Lupus Erythematosus; INTRODUCTION; BIOMARKER DEFINITION AND VALIDATION; BIOMARKERS FOR DIAGNOSIS OF SLE; Cell-Bound Complement Activation Products; Interferon-α and Interferon-α-Inducible Genes; T-Cell Gene Expression Assays; BIOMARKERS FOR MEASURING SLE DISEASE ACTIVITY; Cell-bound Complement Activation Proteins; Interferon-α and Interferon-α-Inducible Genes; B-Lymphocyte Stimulating Factor/B-Cell Activating Factor; CD27high Plasma Cells; CD44+ T Cells; BIOMARKERS TO DETECT SPECIFIC ORGAN INVOLVEMENT; Lupus Nephritis Biomarkers , Antibodies to Complement C1qMonocyte Chemoattractant Protein-1; Neutrophil Gelatinase-Associated Lipocalin; Urinary TWEAK; MicroRNAs; Transferrin, α-1-Acid-Glycoprotein, Ceruloplasmin, Lipocalin-Type Prostaglandin D-Synthase; Hepcidin; Central Nervous System Biomarkers; Anti-NMDA Receptor Antibody; Antiribosomal P Antibody; Antiphospholipid Antibodies; Platelet-Bound C4d; Cardiovascular System Biomarkers; GENETIC SUSCEPTIBILITY AND THERANOSTICS; CONCLUSIONS; REFERENCES; II - Pathogenesis; 8 - Overview of the Pathogenesis of Systemic Lupus Erythematosus; GENETIC PREDISPOSITION , EPIGENETIC CONTRIBUTIONS , English

Weitere Ausg.: ISBN 9780128019177

Weitere Ausg.: ISBN 0128019174

Sprache: Englisch